sever
acut
respiratori
syndrom
sar
seriou
epidem
diseas
dispers
mani
countri
period
time
march
may
extraordinari
period
person
infect
die
china
http
main
symptom
sar
hyperpyrexia
chill
cough
dyspnea
confront
new
human
coronaviru
mani
scientist
devot
relat
research
cowork
discov
genom
sequenc
coronaviru
lit
lamp
perplex
investig
base
marra
work
anand
et
built
main
proteinas
structur
use
homolog
model
approach
indic
exist
proteas
inhibitor
high
bind
affin
sar
coronaviru
proteinas
find
may
help
scientist
design
sar
inhibitor
de
also
believ
similar
hiv
xiong
et
al
found
avail
proteas
inhibitor
mddr
databas
mdl
drug
data
report
http
wwwmdlcom
virtual
lee
et
identifi
four
potent
compound
taken
antivir
drug
nci
databas
nation
cancer
institut
nci
databas
http
recent
report
siroi
et
al
screen
million
compound
virtual
screen
use
moe
softwar
wu
et
also
contribut
excel
work
assay
compound
potent
activ
found
includ
two
exist
drug
present
still
effect
proteas
inhibitor
market
avail
ligand
databas
use
virtual
screen
usual
western
medicin
databas
mddr
nci
acd
etc
tradit
chines
medicin
play
import
role
china
thousand
year
valuabl
sourc
complement
western
medicin
period
peopl
china
use
tcm
prevent
diseas
posit
result
prescript
focu
honeysuckl
lonicera
japonica
caprifoliacea
indigowoad
root
isati
indigotica
crucifera
forsythia
forsythia
suspensa
oleacea
swordlik
atractylod
atractylod
lancea
composita
licoric
glycyrrhiza
uralensi
leguminosa
etc
along
scale
isol
compound
natur
sourc
bigger
bigger
mani
novel
structur
continu
found
peopl
pay
attent
find
new
effect
drug
natur
sourc
especi
medicin
plant
halobio
unlik
live
be
owe
uniqu
habitat
high
salin
littl
light
high
pressur
marin
organ
differ
metabol
rout
fact
result
remark
structur
divers
marin
natur
product
charact
make
marin
natur
product
invalu
treasur
new
compound
isol
sea
live
be
ad
new
compound
new
antineoplast
drug
synthes
compound
origin
isol
tunic
undergo
clinic
test
period
ii
europ
america
expect
come
onto
market
year
articl
use
two
new
natur
product
databas
tradit
chines
medicin
databas
tcmd
marin
natur
product
mnpd
virtual
screen
mnpd
construct
compound
isol
halobio
among
compound
bioactiv
data
ca
registri
number
physic
properti
data
databas
run
isisbas
mdl
inform
system
inc
platform
tcmd
commerci
databas
built
laboratori
http
productscambridgesoftcomfamilycfm
entri
typic
entri
includ
detail
molecular
structur
english
name
synonym
physic
properti
natur
sourc
refer
inform
bioactiv
data
avail
entri
tradit
chines
medicin
plant
speci
includ
standard
express
tcm
effect
indic
mani
antiviru
compound
tcmd
accord
jenwitheesuk
de
groot
find
help
find
proteas
honeysuckl
indigowoad
root
forsythia
swordlik
atractylod
licoric
also
import
effect
compon
tcm
prescript
tcmd
run
isisbas
platform
compound
structur
mnpd
tcmd
transform
molecul
file
concord
standalon
sgi
workstat
accord
lipinski
rule
five
rof
compound
appropri
molecular
weight
mw
donor
acceptor
logp
difficult
molecul
larger
molecular
weight
lower
logp
valu
cross
cell
membran
larger
logp
valu
drug
difficult
dissolv
water
necessari
condit
drug
absorb
organ
xu
extend
rule
definit
cluster
criteria
adopt
see
tabl
filter
two
databas
combin
rof
xu
regul
due
proteas
larger
activ
pocket
expand
mw
less
compound
paramet
meet
rule
pick
written
singl
molecul
file
databas
quickli
narrow
mnpd
tcmd
respect
logp
calcul
xlogp
cowork
report
crystal
structur
proteas
pdb
entri
code
dimer
activ
pocket
locat
protom
contain
three
domain
site
cleft
domain
ii
residu
respect
activ
site
catalyt
dyad
compos
also
pocket
consist
side
chain
atom
packag
linux
version
use
first
step
virtual
screen
comput
carri
cluster
pc
server
comput
node
hpcompaq
industri
standard
server
dual
pentium
iii
cpu
cach
residu
around
sulfur
atom
radiu
isol
construct
grid
dock
screen
energi
score
grid
obtain
use
model
dielectr
function
cutoff
macromolecul
load
kollman
charg
charg
small
molecul
anchor
fragment
orient
method
perform
conform
produc
per
cycl
top
candid
filter
dock
procedur
databas
studi
program
respect
comput
process
sgi
octan
graphic
workstat
grid
space
size
macromolecul
small
molecul
load
kollman
charg
respect
method
adopt
use
default
set
compound
better
autodock
score
bind
conform
select
lead
compound
sar
next
project
energi
score
es
import
criterion
evalu
bind
affin
target
protein
ligand
certain
orient
conform
shortcom
score
function
dock
energi
score
bias
toward
select
high
molecular
liu
provid
new
arithmet
elimin
bia
unpublish
data
liu
z
shi
l
lai
l
h
consid
molecul
weight
virtual
dock
screen
implic
inhibitor
select
found
molecul
heavi
atom
number
ha
interact
target
protein
proper
bind
mode
compound
usual
repres
correct
interact
mode
whole
data
set
wherea
energi
score
molecul
larger
ha
spread
partli
choic
escap
bind
site
pocket
capac
limit
ha
number
averag
energi
score
relationship
describ
eq
mnpd
tcmd
exponenti
decay
fit
curv
mnpd
equat
imag
exponenti
decay
fit
curv
tcmd
equat
imag
figur
give
distribut
curv
heavi
atom
energi
score
repetit
evalu
autodock
compound
high
affin
silico
select
mnpd
tcmd
use
experiment
scientist
priorit
drug
candid
studi
interact
mechan
structur
paramet
list
tabl
coronaviru
famili
exhibit
one
main
proteas
call
natur
catalyt
site
act
crucial
role
regul
viru
residu
consid
essenti
normal
function
sar
protein
dock
simul
compound
isol
pseudomona
sp
alteromona
sp
spong
dysidea
fragili
black
sea
show
inhibitor
fold
structur
activ
site
similar
wu
compound
k
valu
proteas
one
phenyl
group
compound
fit
pocket
defin
etc
one
carbonyl
instead
phenyl
fit
pocket
defin
hydrophob
residu
group
interact
directli
hydrogen
bond
interact
hydrophob
contact
also
four
hydrogen
bond
respect
complex
analyz
ligplot
identifi
specif
contact
fig
sar
target
novel
still
effect
inhibitor
avail
market
report
deriv
might
good
start
point
design
anticoronaviru
drug
alreadi
clinic
test
treatment
common
cold
dock
complex
proteas
also
multipl
interact
similar
recommend
compound
fig
eighteen
compound
best
bind
affin
conform
found
via
virtual
screen
statist
method
interact
bind
mechan
elucid
complex
structur
similar
protein
bind
mode
screen
compound
report
possibl
molecul
sar
inhibitor
show
certain
valu
research
experiment
scientist
priorit
drug
candid
result
show
drug
sar
protein
may
characterist
direct
interact
function
residu
act
crucial
role
regul
sar
life
cycl
